id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0360-0003,FDA,FDA-2011-D-0360,"Framework for Regulatory Oversight of Laboratory Developed Tests; Public
Workshop; Request for Comments",Notice,Request for Comments,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,2015-02-03T04:59:59Z,2015-02-21T03:01:26Z,2014-27713,0,0,090000648194152d
FDA-2011-D-0360-0002,FDA,FDA-2011-D-0360,"Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Laboratories; Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)",Other,Guidance,2014-10-03T04:00:00Z,2014,10,2014-10-03T04:00:00Z,,2024-11-11T20:54:54Z,,1,0,09000064818a7e54
FDA-2011-D-0360-0001,FDA,FDA-2011-D-0360,"Framework for Regulatory Oversight of Laboratory Developed Tests; Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Laboratories; Availability",Notice,Notice of Availability,2014-10-03T04:00:00Z,2014,10,2014-10-03T04:00:00Z,2015-02-03T04:59:59Z,2015-02-22T02:42:09Z,2014-23596,0,0,09000064818a68c5